Prenetics to Take Part in the 38th Annual ROTH Conference

(SeaPRwire) –   NEW YORK, March 18, 2026 — Prenetics Global Limited (PRE) (“Prenetics” or the “Company”), a prominent consumer health sciences firm and parent company of the premium health and longevity brand IM8, announced today that it will take part in the 38th Annual ROTH Conference, which runs from Sunday, March 22nd through Tuesday, March 24th at the Ritz-Carlton in Laguna Niguel, California.

Danny Yeung, CEO of Prenetics, and David Vanderveen, President of Americas, will be on hand for individual meetings during the entire conference. The management team will also take part in a fireside chat at 8:30 a.m. PT and a Consumer Influencer panel discussion at 12:00 p.m. PT on Monday, March 23rd — both of which can be accessed via webcast at the links provided above and on the Company’s investor relations site.

To arrange an individual meeting with Prenetics’ management team, please reach out to Investor Relations at PRE@mzgroup.us or contact your ROTH representative.

About Prenetics

Prenetics (NASDAQ: PRE) is a premier health sciences firm committed to promoting human health and longevity. The Company’s flagship consumer brand, IM8, which was co-founded with David Beckham and is supported by World No. 1 tennis player Aryna Sabalenka, is transforming the premium daily nutrition market through scientifically-supported formulations and international brand collaborations. Since its introduction, IM8 has emerged as one of the most rapidly expanding brands in the consumer health sector, reaching a remarkable benchmark of exceeding $100 million in annualized recurring revenue in only 11 months of operation, and is currently distributed in over 30 countries globally.

About IM8

IM8 represents the ultimate in premium core nutrition, created through a partnership between co-founding partner David Beckham and a distinguished team of scientists from the medical, academic, and space science fields. By merging advanced scientific research with nature’s most powerful ingredients, IM8 provides a comprehensive, scientifically-supported health solution that enables individuals to live their most dynamic lives. IM8’s primary offering, Daily Ultimate Essentials, is a comprehensive powder supplement designed to substitute for 16 separate supplements in a tasty beverage. It holds NSF Certification for Sport, is non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors, or sweeteners. IM8 operates as a subsidiary of Prenetics (NASDAQ: PRE), a top-tier global health sciences firm focused on enhancing consumer health. For additional information about IM8, visit www.IM8health.com.

Investor Relations Contact:

investors@prenetics.com
PRE@mzgroup.us

Angela Cheung
Investor Relations / Corporate Finance
angela.hm.cheung@prenetics.com

This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content.

Category: Top News, Daily News

SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.